BG Medicine (BGMD) Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
5/13/2013 9:38:36 AM
More...
|
BG Medicine (BGMD) Reports 2013 First Quarter Financial Results
5/9/2013 9:56:25 AM
More...
|
BG Medicine (BGMD) Names Dr. Paul Sohmer as CEO
5/9/2013 7:21:26 AM
More...
|
BG Medicine (BGMD)'s BGM Galectin-3 Test to Reduce Rehospitalizations
5/8/2013 10:37:37 AM
More...
|
BG Medicine (BGMD) Receives CE Mark for Galectin-3 Test
4/10/2013 6:49:16 AM
More...
|
BG Medicine (BGMD) Reports Fourth Quarter and Full Year 2012 Financial Results and Provides 2013 Outlook
3/13/2013 11:24:47 AM
More...
|
BG Medicine (BGMD) Highlights Role of Galectin-3 Testing in Combating Hospital Readmissions at the American College of Cardiologyy's (ACC) 62nd Annual Scientific Session & Expo
3/6/2013 11:10:24 AM
More...
|
BG Medicine (BGMD) Announces Publication of Two Studies Supporting Repeat Galectin-3 Testing in Heart Failure Patients
2/27/2013 11:37:07 AM
More...
|
BG Medicine (BGMD) to Present at Cowen and Company 33rd Annual Health Care Conference
2/27/2013 11:35:16 AM
More...
|
BG Medicine (BGMD) Announces Closing of Public Offering and Exercise of Over-Allotment Option
1/31/2013 9:47:52 AM
More...
|
|